摘要
CD+4CD+25调节T(Treg)细胞具有免疫无能性和免疫抑制性两大功能特征,是抑制性T细胞的一种亚群.能抑制效应细胞CD+4T细胞和CD+8T细胞的活化与增殖,从而有效抑制免疫系统对外来器官产生的排异反应,减轻了造血干细胞移植(HSCT)术后移植物抗宿主病(GVHD),而且不影响移植物抗白血病(GVL)效应,从而在移植免疫耐受中发挥重要的作用.
CD+4 CD+25 regulatory T cell (Treg) has immune incompetent and immune suppression functions, and is a kind of suppressor T-cell subsets. It can inhibit the activation and proliferation of CD+4 T cells and CD+8 T cells, so as to effectively suppress the immune system to foreign organ and reduce the graftversus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT), without affecting the role of graft-versus-leukemia (GVL), which plays an important role in the transplantation immune tolerance.
出处
《肿瘤研究与临床》
CAS
2010年第10期718-720,共3页
Cancer Research and Clinic